Evidence map›Paper›PMID 28622198›Full record

ReviewCurrent opinion in pulmonary medicine2017

Ocular sarcoidosis: new diagnostic modalities and treatment.

Sung J Yang, Sherveen Salek, James T Rosenbaum

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in pulmonary medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. A case of oculocutaneous sarcoidosis.American journal of ophthalmology case reports · 2023
    Article
  8. Sarcoid Uveitis: An Intriguing Challenger.Medicina (Kaunas, Lithuania) · 2022
    Review
  9. Article
  10. Progress in the diagnosis of ocular sarcoidosis.Indian journal of ophthalmology · 2022
    Review
  11. Pediatric uveitis: Role of the pediatrician.Frontiers in pediatrics · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Intraocular biopsy in uveitis.Indian journal of ophthalmology · 2020
    Review
  17. Refractory Sarcoidosis: A Review.Therapeutics and clinical risk management · 2020
    Review
  18. Article
  19. Article
  20. Sarcoidosis: a review for the internist.Internal and emergency medicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Sung J YangaDepartment of Ophthalmology, Gangneung Asan Hospital, Ulsan University, South Korea bCasey Eye Institute cDivision of Arthritis and Rheumatic Diseases, Oregon Health & Science University dLegacy Devers Eye Institute, Portland, Oregon, USA.
Sherveen Salek
James T Rosenbaum
GTx (United States) · USOregon Health & Science University · US

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell · 1995 to 2026
$19.4M
Gene Expression in Nonspecific Orbital Inflammatory DiseaseR01EY020249 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ROSENBAUM, JAMES T · 2011 to 2020
$5.0M
NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY020249
6 · The paper itself

Abstract

purpose of reviewOcular involvement in sarcoidosis is present in up to 80% of patients and is frequently manifested before diagnosis of the underlying systemic disease. Considering the therapeutic consequences, early diagnosis of the underlying disease is advantageous in patients presenting with ocular inflammation. There are several ocular findings suggestive of underlying sarcoidosis, such as granulomatous keratic precipitates, iris nodules, cells in the vitreous humor known as snowballs and snowbanks, and retinal periphlebitis. High suspicion is crucial for the diagnosis of sarcoidosis. This review on ocular sarcoidosis will mainly focus on new diagnostic and treatment modalities. RECENT

findingsRecent studies found possible new diagnostic indicators for the diagnosis of ocular sarcoidosis which include not only serum profiles but also vitreous sample analysis. Ophthalmologic imaging techniques have improved to investigate the ocular structure in detail. Results from recent uveitis clinical trials have included sarcoidosis as an underlying cause and have reported positive results. SUMMARY: The diagnosis of ocular sarcoidosis can be challenging in some cases. High suspicion is important to diagnose ocular sarcoidosis with various laboratory and ophthalmic tools. There are many possible options for the treatment of ocular sarcoidosis including various biologic agents.

Indexed as

Eye DiseasesSarcoidosisDiagnostic Techniques, OphthalmologicalDisease ManagementEarly DiagnosisHumans

Identifiers

PMID28622198
PMCPMC5642043
OpenAlexW2627003493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.